226 related articles for article (PubMed ID: 35966826)
21. Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study.
Reece AS; Hulse GK
BMC Cancer; 2021 Sep; 21(1):984. PubMed ID: 34479489
[TBL] [Abstract][Full Text] [Related]
22. Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis.
Reece AS; Hulse GK
Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):699-717. PubMed ID: 35779123
[TBL] [Abstract][Full Text] [Related]
23. Broad Spectrum epidemiological contribution of cannabis and other substances to the teratological profile of northern New South Wales: geospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Pharmacol Toxicol; 2020 Nov; 21(1):75. PubMed ID: 33183341
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological association of cannabinoid- and drug- exposures and sociodemographic factors with limb reduction defects across USA 1989-2016: A geotemporospatial study.
Reece AS; Hulse GK
Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100480. PubMed ID: 35691647
[TBL] [Abstract][Full Text] [Related]
25. Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac006. PubMed ID: 35386387
[TBL] [Abstract][Full Text] [Related]
26. Causal inference multiple imputation investigation of the impact of cannabinoids and other substances on ethnic differentials in US testicular cancer incidence.
Reece AS; Hulse GK
BMC Pharmacol Toxicol; 2021 Jul; 22(1):40. PubMed ID: 34246312
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.
Reece AS; Hulse GK
Sci Rep; 2021 Jul; 11(1):13892. PubMed ID: 34230557
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805384
[TBL] [Abstract][Full Text] [Related]
29. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity.
Reece AS; Hulse GK
Mutat Res; 2016 Jul; 789():15-25. PubMed ID: 27208973
[TBL] [Abstract][Full Text] [Related]
30. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213
[TBL] [Abstract][Full Text] [Related]
31. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
[TBL] [Abstract][Full Text] [Related]
32. Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al.
Reece AS; Hulse GK
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672773
[TBL] [Abstract][Full Text] [Related]
33. Canadian Cannabis Consumption and Patterns of Congenital Anomalies: An Ecological Geospatial Analysis.
Reece AS; Hulse GK
J Addict Med; 2020; 14(5):e195-e210. PubMed ID: 32187114
[TBL] [Abstract][Full Text] [Related]
34. Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.
Reece AS; Hulse GK
Front Psychiatry; 2023; 14():1182535. PubMed ID: 37732074
[TBL] [Abstract][Full Text] [Related]
35. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.
Manthey J; Freeman TP; Kilian C; López-Pelayo H; Rehm J
Lancet Reg Health Eur; 2021 Nov; 10():100227. PubMed ID: 34806072
[TBL] [Abstract][Full Text] [Related]
36. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554603
[TBL] [Abstract][Full Text] [Related]
37. Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.
Wiegand DM; Methner MM; Grimes GR; Couch JR; Wang L; Zhang L; Blount BC
Ann Work Expo Health; 2020 Aug; 64(7):705-714. PubMed ID: 32219297
[TBL] [Abstract][Full Text] [Related]
38. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Niesink RJ; Rigter S; Koeter MW; Brunt TM
Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
[TBL] [Abstract][Full Text] [Related]
39. Potency of Δ
Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M
Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730
[TBL] [Abstract][Full Text] [Related]
40. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.
Colizzi M; Ruggeri M; Bhattacharyya S
Front Psychol; 2020; 11():833. PubMed ID: 32528345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
